Infection with adenovirus, a common childhood virus, is the leading hypothesis for recent cases of severe hepatitis of unknown origin in children that have led to at least six deaths, U.S. health officials said on May 20.
As U.S. COVID-19 cases rise, so does demand for antiviralsAntivirals, Apple, BNT162b2 (Pfizer and BioNTech), CDC, Connecticut, COVID-19 booster shots, COVID-19 cases, COVID-19 Therapeutics, COVID-19 Vaccines, Delaware, Department of Health and Human Services (HHS), Emergency Use Authorization (EUA), FDA, Health Officials, Hospitalized COVID-19 Patients, Maine, Massachusetts, Merck, Molnupiravir, New York, Northeast, Omicron (B.1.1.529) (South Africa), Omicron BA.2, Paxlovid, Pfizer, Regions, Reuters Tally, Rhode Island, Therapeutics, U.S. government, United States, White House
Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc.’s oral antiviral treatment Paxlovid seeing a 315 percent jump over the past four weeks, U.S. health officials said on May 17.
White House launches COVID.gov amid push for more funds, booster shotsBNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Cases, COVID-19 booster shots, COVID-19 Vaccines, Democrats, Funding, Health Officials, Immunocompromised, Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Websites, White House
The Biden administration on Wednesday launched a new website to provide a clearinghouse of information on COVID-19 as part of a continuing effort to prepare Americans to live with the coronavirus.
An AstraZeneca Plc executive said the British drugmaker would consider not submitting the company’s COVID-19 vaccine for approval in the United States if the regulatory process takes too long, the Financial Times reported on March 17.
White House readies roadmap for future COVID outbreaks, seeks fundingAntivirals, Business, Congress, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibody Tests, COVID-19 Deaths, Covid-19 Variants, Dr. Anthony Fauci (Director), Health Officials, Joe Biden, National Institute of Allergy and Infectious Diseases (NIAID), Outbreaks, Pandemics, Pharmacy, Reuters Analysis, Schools
Top U.S. health officials on March 2 laid out a national blueprint to manage COVID-19 going forward, vowing to prepare for any new variant outbreaks without shutting down schools and businesses and calling for additional funding from Congress.
Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.
Top U.S. infectious disease expert Dr. Anthony Fauci said on February 16 that it is time for the United States to start inching back towards normality, despite remaining risks from COVID-19.
U.S. coronavirus deaths surpass 900,000, driven in part by Omicron surgeAfrica, Brazil, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Deaths, COVID-19 Vaccinations, Delta Variant (B.1.617.2; India), Health Officials, India, Iowa, Joe Biden, Omicron (B.1.1.529) (South Africa), Peru, Reuters Data, Russia, United States
The coronavirus pandemic reached a grim new milestone in the United States on Feb. 4 with the nation’s cumulative death toll from COVID-19 surpassing 900,000, even as the daily number of lives lost began to level off, according to data collected by Reuters.
Kate Rawson, one of the most insightful and practical observers of the health policy scene in Washington, offers the Coalition for Healthcare Communication her well-informed analysis and a Q&A format.
President Joe Biden and top health officials on January 11 defended the government’s response to the unrelenting pandemic as daily U.S. COVID-19 cases reached a new high, largely fueled by the highly contagious Omicron variant.